FDA Clearance May Thwart Monograph Goal; Ganley Talks Turkey About ONP

The Office of Nonprescription Products' goal of completing all OTC monographs by 2010 is viable only if FDA improves its document clearance process, according to ONP head Charles Ganley, MD